A case series showed that levels of biomarkers of inflammation in cerebrospinal fluid (CSF), including neopterin and β2-microglobulin, increased in six COVID-19 patients with neurological symptoms, including encephalopathies, suspected meningitis, and dysgeusia [82]. The gene discussed is HLA-G; the disease is infectious meningitis.